Apr 29, 2016 at 12:46 | Source: PTI
"Glenmark Pharmaceuticals, USA, has been granted tentative approval by the US Food and Drug Administration (USFDA) for adapalene and benzoyl peroxide gel, 0.1 percent/ 2.5 percent," it said in a BSE filing today.
Apr 26, 2016 at 11:24 | Source: PTI
Glenmark Pharmaceuticals USA has been granted tentative approval by the USFDA for Norethindrone Acetate and Ethinyl Estradiol tablets USP, 1 mg/0.01 mg, Ethinyl Estradiol tablets USP, 0.01 mg and Ferrous Fumarate tablets, 75 mg, the generic version of Lo Loestrin Fe, the company said in a BSE filing today.
Apr 26, 2016 at 10:50 | Source: Moneycontrol.com
Glenmark Pharmaceuticals Inc. USA has been granted tentative approval by the USFDA for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.01 mg, Ethinyl Estradiol Tablets USP, 0.01 mg and Ferrous Fumarate Tablets, 75 mg.
Apr 26, 2016 at 09:10 | Source: CNBC-TV18
Ashwani Gujral of ashwanigujral.com recommends buying Jet Airways, Tata Chemicals and Glenmark Pharma and advises selling Bharat Forge and IRB Infra.
Apr 26, 2016 at 08:02 | Source: CNBC-TV18
Bharti Airtel | Hero Motocorp | Sun Pharma | Linde India | Prism Cement | Engineers India | Avon Lifesciences | Tata Chemicals | Infosys | Wipro | Dewan Housing | Excel Corp Care | ABB India | Indiabulls Housing Finance | Delta Corp and ITC are stocks, which are in the news today.
Apr 22, 2016 at 15:24 | Source: CNBC-TV18
Ashwani Gujral of ashwanigujral.com is of the view that one can sell Voltas and Dabur India and advises selling Glenmark Pharma.
Apr 22, 2016 at 12:09 | Source: CNBC-TV18
Even as the frontline pharma companies such asSun, Cipla, Dr Reddy's and Lupin have increased regulatory scrutiny, R Sreesankar of Prabhudas Lilladher sees value in smaller rivals such as Glenmark, Aurobindo and Jubilant Life.
Apr 21, 2016 at 13:56 | Source: PTI
"The Indore plant was inspected by USFDA in February 2016 and we received three observations from them which were responded to in March 2016," Glenmark Pharmaceuticals said in a regulatory filing.
Apr 21, 2016 at 13:34 | Source: CNBC-TV18
CA Rudramurthy BV of Vachana Investments recommmends selling Glenmark Pharma as the stock may test Rs 730.